BioCentury
ARTICLE | Financial News

Cancer play Kolltan raises $60 million in series D

March 27, 2014 12:34 AM UTC

Kolltan Pharmaceuticals Inc. (New Haven, Conn.) raised $60 million in a series D round led by a new, undisclosed institutional asset manager and existing investor KLP Enterprises. New investors, including Deerfield Management and Franklin Berger, also participated, along with existing investors, including HBM Healthcare Investments; Purdue Pharma L.P. (Stamford, Conn.); Osage University Partners; and C.T. Koll. ...